Patent Assignment
Reel/Frame 063662/0455
Change of Name
Recorded: 2023-05-16
Pages: 4
Assignor
CUREVAC AG
Executed: 2022-09-26
Assignee
CUREVAC SE
FRIEDRICH-MIESCHER-STRASSE 15, TÜBINGEN, 72076, GERMANY
Covered Properties
(2)
RNA vaccine against SARS-CoV-2 variants
RNA vaccine against SARS-CoV-2 variants
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 9, 2022
From: ROTH, NICOLE, DR.; MORENO, DIEGO CHAVES; GROSSE, HANS WOLFGANG, DR.; VAHRENHORST, DOMINIK
To: CUREVAC AG; GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 058938/0857 →
Assignment of Assignor's Interest
Jun 1, 2022
From: ROTH, NICOLE; MORENO, DIEGO CHAVES; GROSSE, HANS WOLFGANG; VAHRENHORST, DOMINIK
To: CUREVAC AG; GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 060076/0634 →
Assignment of Assignor's Interest
Sep 17, 2024
From: CUREVAC SE
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 068605/0741 →
Assignment of Assignor's Interest
Sep 17, 2024
From: CUREVAC SE
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 068605/0892 →
Corrective Assignment to Correct the the Recorded Assignment to Include the Authorized Signatory's Printed Name for Curevac Se. Previously Recorded on Reel 68605 Frame 741. Assignor(S) Hereby Confirms the Assignment.
Sep 27, 2024
From: CUREVAC SE
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 069068/0321 →
Corrective Assignment to Correct the Signature of Inventor on the Assignment Document Previously Recorded at Reel: 68605 Frame: 0892. Assignor(S) Hereby Confirms the Assignment .
Oct 4, 2024
From: CUREVAC SE
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 069116/0881 →